HealthRegulation
FDA Panel Backs Broader Access to Gray Market Peptides
FDA panel voted to ease restrictions on six peptides, allowing compounding pharmacies to produce them and potentially curbing the unregulated gray market.
—5 min read
Tag
#Peptides
2 articles
HealthPolitics
FDA Panel Narrowly Backs Unapproved Peptide Drug BPC-157
FDA advisory panel voted 8-6 to broaden access to BPC-157, an unapproved peptide popularized by RFK Jr. and Joe Rogan, despite safety concerns.
—6 min read